Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of GoodwillAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AdaptHealth (AHCO) Net Cash Flow (2018 - 2025)

AdaptHealth (AHCO) has 8 years of Net Cash Flow data on record, last reported at $25.8 million in Q4 2025.

  • For Q4 2025, Net Cash Flow rose 169.46% year-over-year to $25.8 million; the TTM value through Dec 2025 reached -$3.6 million, down 111.07%, while the annual FY2025 figure was -$3.6 million, 111.07% down from the prior year.
  • Net Cash Flow reached $25.8 million in Q4 2025 per AHCO's latest filing, up from $11.7 million in the prior quarter.
  • Across five years, Net Cash Flow topped out at $158.5 million in Q3 2021 and bottomed at -$187.0 million in Q4 2021.
  • Average Net Cash Flow over 5 years is $308700.0, with a median of $10.3 million recorded in 2023.
  • The widest YoY moves for Net Cash Flow: up 282.55% in 2023, down 8991.28% in 2023.
  • A 5-year view of Net Cash Flow shows it stood at -$187.0 million in 2021, then soared by 65.53% to -$64.5 million in 2022, then surged by 132.56% to $21.0 million in 2023, then crashed by 54.42% to $9.6 million in 2024, then surged by 169.46% to $25.8 million in 2025.
  • Per Business Quant database, its latest 3 readings for Net Cash Flow were $25.8 million in Q4 2025, $11.7 million in Q3 2025, and $15.0 million in Q2 2025.